Company / Operating Cash Flow per Share
ResMed Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$11.92
FY2025
5-year range
$2.41 / $11.92
FY2021-FY2025
Trend
+25.1%
vs FY2024
Sector context
#23 of 155
Health Care
What the data says
ResMed's operating cash flow per share of $11.92 is higher than 85% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has increased for 3 consecutive years, from $2.41 in FY2022 to $11.92 in FY2025.
Based on SEC 10-K filings.
11.92 in FY2025 with a 5-year CAGR of +16.4%. Top quartile in the Health Care sector.
Improved from $4.74 to $11.92 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +70.4%
- 5-Year CAGR
- +16.4%
- 10-Year CAGR
- -
Sector benchmark
+76.0% above sector average
Key checks
Key Insights
- ResMed's operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 25.1% year-over-year.
- Ranks #23 out of 155 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.92 | +25.1% |
| FY2024 | $9.53 | +101.2% |
| FY2023 | $4.74 | +96.4% |
| FY2022 | $2.41 | -52.6% |
| FY2021 | $5.08 | -9.0% |
| FY2020 | $5.58 | +73.6% |
| FY2019 | $3.22 | -9.4% |
| FY2018 | $3.55 | +20.7% |
| FY2017 | $2.94 | -24.5% |
| FY2016 | $3.90 | +42.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026